Atlas Trials

Randomized Controlled Trial of Intranasal Ketamine vs. Intranasal Midazolam in Individuals With OCD

Clinical trial NCT02206776 · TERMINATED

Trial details

NCT number
NCT02206776
Sponsor
New York State Psychiatric Institute
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Obsessive-Compulsive Disorder
Start date
2014-09-01
Primary completion
2015-05-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.